Oct 6 (Reuters) - The U.S. Securities and Exchange Commission has been probing marketing platform AppLovin's (APP.O), opens new tab data-collection practices, Bloomberg News reported on Monday, citing ...

(Reuters) -The U.S. Securities and Exchange Commission has been probing marketing platform AppLovin's data-collection practices, Bloomberg News reported on Monday, citing people familiar with the ...

WATERTOWN, Mass., Oct. 13, 2025 (GLOBE NEWSWIRE) -- Remix Therapeutics (Remix), a clinical-stage biotechnology company developing small molecule therapies to modulate RNA processing and address the ...

RADNOR, Pa. and SOUTH SAN FRANCISCO, Calif., Oct. 13, 2025 (GLOBE NEWSWIRE) -- Quanta Therapeutics, a privately-held clinical-stage biopharmaceutical company leading the development of innovative, ...

30-day Data from the AMDS PERSEVERE Trial Demonstrates Visceral Malperfusion Resolution in 83%, and Renal Malperfusion Resolution in 74% of Affected Subjects Post-AMDS Implantation Real-World Data ...

The federal shutdown is on the verge of ripping a hole in the government’s ability to deliver market-moving reports on inflation and employment. The longer Congress is stuck in a stalemate over ...

AppLovin Corp (NASDAQ:APP) slumped Monday afternoon after Bloomberg reported the SEC is probing the mobile ad-tech firm's data-collection practices, including possible breaches of partners' service ...

Pulse Biosciences Announces Presentation of Late-Breaking Data From the nPulse™ Cardiac Surgical System First-in-Human Feasibility Study at the 39th European Association for Cardio-Thoracic Surgery ...

This study utilized deidentified patient data from the National Cancer Database (NCDB). The data are not publicly available but can be accessed through application to the NCDB by eligible ...

Investopedia contributors come from a range of backgrounds, and over 25 years there have been thousands of expert writers and editors who have contributed. Amy is an ACA and the CEO and founder of ...